"Both computational chemists and medicinal chemists have explored the Molecule Evoluator and have been excited about the output in terms novel ideas being generated and the potential for further enhancements in the future. The real advantage of the current programme is that it can be iteratively influenced by trained chemists to propose new structures, some of which may look immediately obvious but yet had not been previously suggested. Three of our current GPCR-based projects have benefited in this way."
John Saunders, PhD, Senior Vice President of Research (Chemistry)
